An evidence-based review on the use of corticosteroids in peri-operative and critical care

Acta Anaesthesiologica Sinica

Volumn 40, Issue 2, 2002, Pages 71-79

  Han, Yin Yi ^a   Sun, Wei Zen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adrenal cortex hormones; Critical care; Perioperative care

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; BUDESONIDE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; CORTISONE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; LIVE VACCINE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MINERALOCORTICOID; PLACEBO; PREDNISOLONE; PREDNISONE; STEROID; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE HEXACETONIDE;

ACUTE RESPIRATORY FAILURE; ADRENAL INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; ANAPHYLACTIC SHOCK; ASPIRATION PNEUMONIA; ASTHMA; BRAIN ABSCESS; BRAIN INFARCTION; BRAIN TUMOR; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MEGADOSE; DRUG USE; EDEMA; EVIDENCE BASED MEDICINE; FAT EMBOLISM; HEAD INJURY; HEART ARREST; HUMAN; HYPOTHERMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRACRANIAL HYPERTENSION; MYCOSIS; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; REVIEW; SEPTIC SHOCK; SPINAL CORD INJURY; THYROID CRISIS; VACCINATION; VOMITING;

ADRENAL CORTEX HORMONES; ADRENAL INSUFFICIENCY; ASTHMA; CRITICAL CARE; EVIDENCE-BASED MEDICINE; GLUCOCORTICOIDS; HUMANS; INTRACRANIAL PRESSURE; PERIOPERATIVE CARE; SPINAL CORD INJURIES;

EID: 0036063726     PISSN: 02541319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. What is the cause of Cushing's disease?
2. Acute adrenal insufficiency
3. Perioperative glucocorticoid coverage: A reassessment of 42 years after emergence of a problem
4. Current concepts: Adrenal insufficiency
5. New NHLBI guidelines for the diagnosis and management of asthma. National Health, Lung and Blood Institute
6. Canadian consensus on the treatment of asthma in children
7. The role of corticosteroids in the management of childhood asthma
8. Corticosteroids in the emergency department therapy of acute adult asthma: An evidence-based evaluation
9. Asthma mortality in Australia
10. MJA practice essentials-respiratory medicine: Asthma in children
11. Inhaled steroids and the risk of hospitalization for asthma
12. Beclomethasone dipropionate 250 mug per dose metered dose inhalers: Effect of Volumatic spacer on potentially respirable dose
13. Third International Pediatric Consensus statement on the management of childhood asthma
14. Acute adult asthma - Assessment of severity and management and comparison with British Thoracic Society Guidelines
15. Establishment and evaluation of a preschool asthma programme: A pilot study
16. Management of anaphylactic reactions to food
17. Laryngeal oedema following anaphylactic shock
18. Emergency medical treatment of anaphylactic reactions
19. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care
20. Spinal cord injury and glucocortical steroid therapy: Good news and bad
21. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury
22. Administration of methylprednisolone for 24 or 48 h or tirilazad mesylate for 48 h in the treatment of acute spinal cord injury: Results of teh Third National Acute Spinal Cord Injury randomized controlled trial
23. Steroids and gunshot wounds to the spine
24. Spinal cord regeneration in adult goldfish: Implications for functional recovery in vertebrates
25. Management of increased intracranial pressure: A review for clinicians
26. Corticosteroids in acute traumatic brain injury: Systematic review of randomised controlled trials
27. Early changes in peritumorous oedema and contralateral white matter after dexamethasone: A study using proton magnetic resonance spectroscopy
28. Effect of glucocorticoids on ICP in patients with a cerebral tumour
29. Dexamethasone as an antiemetic in patients treated with cisplatin
30. Dexamethasone for the prevention of postoperative nausea and vomiting: A quantitative systemic review
31. Dexamethasone alone does not prevent postoperative nausea and vomiting in women undergoing dilatation and curettage: A comparison with droperidol and saline
32. Adrenocorticotropic hormone, adrenocortical steroids and their synthetic analogs, inhibitors of the synthesis and actions of adrenocortical hormones
33. Prophylactic antiemetic effect of dexamethasone in women undergoing ambulatory laparoscopic surgery
34. Prevention of PONV with dexamethasone in female patients undergoing desflurane anesthesia for thyroidectomy
35. The effect of timing of dexamethasone administration on its efficacy as a prophylactic antiemetic for postoperative nausea and vomiting
36. Dexamethasone for preventing nausea and vomiting associated with epidural morphine: A dose-ranging study
37. Life-threatening thyrotoxicosis. Thyroid storm
38. Decreased adrenal responsiveness in hypothermic patients
39. Hypothermia and adrenocortical function
40. Accidental hypothermia
41. The acute respiratory distress syndrome
42. Are corticosteroids salvage therapy for refractory acute respiratory distress syndrome?
43. Corticosteroid therapy in acute respiratory distress syndrome: Better late than never?
44. New therapies for ARDS
45. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial
46. Fat embolism syndrome: A review of the pathophysiology and physiologic basis of treatment
47. Fat embolism syndrome
48. "Low-dose" corticosteroid prophylaxis against fat embolism
49. Fat embolism syndrome
50. Fat embolism syndrome
51. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease
52. Effect of systemic flucocorticoids on exacerbations of chronic obstructive pulmonary disease
53. Systemic corticosteroids for chronic obstructive pulmonary disease: Benefits and risks
54. Pulmonary aspiration: High dose steroids should be abandoned
55. Rapid improvement of peak flow in asthmatic patients treated with parenteral methylprednisolone in the emergency department: A randomized controlled study
56. Gas embolism in obstetrics and gynecology
57. Gas embolism
58. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock
59. Pathophysiology and treatment of septic shock
60. Septic shock: Treatment
61. Guidelines for the use of systemic glucocorticoids in the management of selected infections
62. Steroid controversy in sepsis and septic shock: A meta-analysis
63. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin
64. Adrenal insufficiency in septic shock
65. Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study
66. Reversal of late septic shock with supraphysiologic doses of hydrocortisone
67. Evaluation of risk factors for laryngeal edema after tracheal extubation in adults and its prevention by dexamethasone: A placebo-controlled, double-blind, multicenter study
68. Complications of tracheal intubation and tracheostomy
69. Dexamethasone for the prevention of postextubation airway obstruction: A prospective, randomized, double-blind, placebo-controlled trial
70. Effectiveness of dexamethasone in preventing extubation failure in preterm infants at increased risk for airway edema
71. Routine use of dexamethasone for the prevention of postextubation respiratory distress
72. Dexamethasone in the prevention of postextubation stridor in children
73. Postextubation laryngeal edema in adults. Risk factor evaluation and prevention by hydrocortisone
74. Glucocorticoid treatment does not improve neurological recovery following cardiac arrest: Brain Resuscitation Clinical Trial I Study Group
75. Guidelines for drug prescription in patients with the acute porphyrias
76. Acute myopathy associated with combined use of corticosteroids and neuromuscular blocking agents
77. Corticosteroids and adrenal suppression: Characterising and avoiding the problem
78. Acute and long-term complications of corticosteroid pulse therapy